The Università degli Studi di Milano (UMIL) is a public institution of lofty culture, home of research and academic activities. The mission of the University, established in 1924, is to contribute to society through the pursuit of teaching/education and research at the highest international levels of excellence. It is the only Italian member among the 23 prestigious Universities of the League of European Research Universities (LERU).

The Global Health Centre (GHC), part of a newly established Centre for Coordinated Research (CRC) named “Center of Multidisciplinary Research in Health Sciences”, focuses its activities on the main themes in global health today, including that of tuberculosis (TB) control and elimination world-wide. The Centre, devoted to research and didactics, provides epidemiological, policy & clinical trial expertise as well as wide networking capacity thanks to the leadership role by Prof. Mario C. Raviglione, who, as former WHO Global TB Programme Director, is an expert of global policies development & analysis, policy & research issues in the global TB response.

Previous long-term work by Prof. Raviglione and his team at the World Health Organization resulted in major normative decisions concerning research and clinical trial design. These include recommendations on research priorities as well as guidance to all countries and stakeholders on adoption of new drugs and design of trials to assess new combination regimens. In addition, Prof. Raviglione’s expertise and knowledge of global TB control and elimination activities, from research, policy and practice perspectives, is a guarantee that the outcomes of the project at stake will be responding to the real needs of countries that will adopt new drugs and regimens, as well as being placed in proper policy language to constitute a normative framework that can apply to all settings, including and especially those in high-burden TB countries.